Latest Trials
| EudraCT Number: 2012-005496-14 | Sponsor Protocol Number: MRZ60201_3072_1 | Start Date: | |||||||||||
| Sponsor Name: Merz Pharmaceuticals GmbH | |||||||||||||
| Full Title: Prospective, multicenter, randomized, double-blind, parallel-group, dose-response study of three doses Xeomin® (incobotulinumtoxinA, NT 201) for the treatment of upper limb spasticity alone or comb... | |||||||||||||
| Medical condition: Upper limb spasticity or combined upper and lower limb spasticity in children and adolescents (age 2 - 17 years) with cerebral palsy | |||||||||||||
|
|||||||||||||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: PL (Completed) Outside EU/EEA | |||||||||||||
| Trial results: View results | |||||||||||||